OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
16
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Publication Date
Release Date
2025
(4)
2021
(3)
2024
(2)
2023
(2)
2022
(1)
2020
(1)
2018
(1)
2016
(1)
2012
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Pembrolizumab in relapsed or refractory Richter syndrome.
Not available
S-EPMC7496875
|
biostudies-literature
Cite
Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma.
Not available
S-EPMC8945583
|
biostudies-literature
Cite
Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy.
Not available
S-EPMC8574211
|
biostudies-literature
Cite
Brain-wide representations of prior information in mouse decision-making.
Not available
S-EPMC12408363
|
biostudies-literature
Cite
A brain-wide map of neural activity during complex behaviour.
Not available
S-EPMC12408349
|
biostudies-literature
Cite
Lightning Pose: improved animal pose estimation via semi-supervised learning, Bayesian ensembling and cloud-native open-source tools.
Not available
S-EPMC12087009
|
biostudies-literature
Cite
Reproducibility of in vivo electrophysiological measurements in mice.
Not available
S-EPMC12068871
|
biostudies-literature
Cite
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.
Not available
S-EPMC6119152
|
biostudies-literature
Cite
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma.
Not available
S-EPMC7993097
|
biostudies-literature
Cite
A common computational and neural anomaly across mouse models of autism.
Not available
S-EPMC12403184
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets